IMPACT2 R&D project gave us the chance to use MDR bacterial strains

For the development of antimicrobials and novel anti-virulence drugs.



Thanks to the IMPACT2 AMR research program carried out over the last few years, we are pleased to announce that we have a range of validated bioluminescents models to conduct studies on antibiotics to fight against multi-resistant bacteria.


To learn more about our models, please take a look on the IMPACT2 AMR website :